Search research articles
Contact Us
Filters
Showing results (1051-1060 of 1,198) with videos related to
Page
of 120
Sort By:
Cancer
|
December 26, 2023
Validation of the RSClin risk calculator in the National Cancer Data Base
Augustin G L Vannier, Asim Dhungana, Fangyuan Zhao, et al.
Transplantation Direct
|
September 21, 2018
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
Stephan Busque, Flavio G Vincenti, Helio Tedesco Silva, et al.
European Urology Oncology
|
September 30, 2019
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer
Heather J Chalfin, Stephanie A Glavaris, Michael A Gorin, et al.
The Prostate
|
January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)
Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients
Theresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
World Journal of Urology
|
September 22, 2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer
Axel S Merseburger, Andrea B Apolo, Simon Chowdhury, et al.
Cancer Immunology Research
|
June 8, 2017
Intravesical BCG Induces CD4<sup>+</sup> T-Cell Expansion in an Immune Competent Model of Bladder Cancer
Max Kates, Thomas Nirschl, Nikolai A Sopko, et al.
The Oncologist
|
April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma
Tomi Jun, Noah M Hahn, Guru Sonpavde, et al.
Brachytherapy
|
April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer
, Steven J Frank, V Elayne Arterbery, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response
Ramesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Page
of 120
Search research articles
Search
Showing results (1051-1060 of 1,198) with videos related to
Sort By:
Page
of 120
Cancer
|
December 26, 2023
Validation of the RSClin risk calculator in the National Cancer Data Base
Augustin G L Vannier, Asim Dhungana, Fangyuan Zhao, et al.
Transplantation Direct
|
September 21, 2018
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
Stephan Busque, Flavio G Vincenti, Helio Tedesco Silva, et al.
European Urology Oncology
|
September 30, 2019
Circulating Tumor Cell and Circulating Tumor DNA Assays Reveal Complementary Information for Patients with Metastatic Urothelial Cancer
Heather J Chalfin, Stephanie A Glavaris, Michael A Gorin, et al.
The Prostate
|
January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)
Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients
Theresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
World Journal of Urology
|
September 22, 2018
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer
Axel S Merseburger, Andrea B Apolo, Simon Chowdhury, et al.
Cancer Immunology Research
|
June 8, 2017
Intravesical BCG Induces CD4<sup>+</sup> T-Cell Expansion in an Immune Competent Model of Bladder Cancer
Max Kates, Thomas Nirschl, Nikolai A Sopko, et al.
The Oncologist
|
April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma
Tomi Jun, Noah M Hahn, Guru Sonpavde, et al.
Brachytherapy
|
April 19, 2011
American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer
, Steven J Frank, V Elayne Arterbery, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response
Ramesh Rengan, Rosemarie Mick, Daniel Pryma, et al.
Page
of 120